Related Experiment Video
Updated: May 14, 2026
08:53
Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
Defined Folate-PEG-siRNA Conjugates for Receptor-specific Gene Silencing
Christian Dohmen1, Thomas Fröhlich, Ulrich Lächelt
1Pharmaceutical Biotechnology, Center of System-based Drug Research, Center for Nanoscience, Ludwig-Maximilians-University, Munich, Germany.
Molecular Therapy. Nucleic Acids
|January 25, 2013
Summary
This study developed a precisely defined folic acid-PEG-siRNA conjugate for targeted cancer therapy. This conjugate achieves efficient gene silencing in cancer cells overexpressing the folic acid receptor.
Area of Science:
- Biotechnology
- Nanomedicine
- Cancer Therapeutics
Background:
- Gene silencing using small interfering RNA (siRNA) is a promising cancer treatment strategy.
- Current polycationic delivery systems for nucleic acids are often heterogeneous.
- Developing structurally defined delivery systems is crucial for targeted therapies.
Purpose of the Study:
- To develop a structurally defined folic acid-PEG-siRNA conjugate for targeted gene silencing.
- To synthesize a monodisperse ligand-PEG-siRNA conjugate using click chemistry.
- To evaluate the efficiency of gene silencing in folic acid receptor-expressing cells.
Main Methods:
- Synthesis of a folic acid targeting ligand using solid-phase peptide chemistry.
- Development of a folic acid-PEG-siRNA conjugate via click chemistry.
- Combination with a structurally defined polycation for enhanced delivery.
- Assessment of cellular uptake and gene silencing efficacy.
Main Results:
- A monodisperse folic acid-PEG-siRNA conjugate was successfully synthesized.
- The conjugate demonstrated specific internalization into folic acid receptor-positive cells.
- Combined with a defined polycation, efficient and receptor-specific gene silencing was achieved.
Conclusions:
- Structurally defined folic acid-PEG-siRNA conjugates represent a precise approach for targeted cancer gene silencing.
- This method overcomes the heterogeneity issues of traditional polycationic delivery systems.
- The developed system shows potential for novel cancer therapeutics.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30Small interfering RNAs (siRNA)
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
02:57piRNA - Piwi-interacting RNAs
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...